These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 19589624)
1. Synthesis and vasodilatory activity of some amide derivatives of 6-(4-carboxymethyloxyphenyl)-4,5-dihydro-3(2H)-pyridazinone. Bansal R; Kumar D; Carron R; de la Calle C Eur J Med Chem; 2009 Nov; 44(11):4441-7. PubMed ID: 19589624 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of 2-substituted-6-phenyl-4,5-dihydropyridazin-3(2H)-ones as potent inodilators. Kumar D; Carron R; La Calle CD; Jindal DP; Bansal R Acta Pharm; 2008 Dec; 58(4):393-405. PubMed ID: 19103574 [TBL] [Abstract][Full Text] [Related]
3. Pyridazinone derivatives: design, synthesis, and in vitro vasorelaxant activity. Abouzid K; Abdel Hakeem M; Khalil O; Maklad Y Bioorg Med Chem; 2008 Jan; 16(1):382-9. PubMed ID: 17905589 [TBL] [Abstract][Full Text] [Related]
4. Some pyrrole substituted aryl pyridazinone and phthalazinone derivatives and their antihypertensive activities. Demirayak S; Karaburun AC; Beis R Eur J Med Chem; 2004 Dec; 39(12):1089-95. PubMed ID: 15571871 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers. Cho H; Katoh S; Sayama S; Murakami K; Nakanishi H; Kajimoto Y; Ueno H; Kawasaki H; Aisaka K; Uchida I J Med Chem; 1996 Sep; 39(19):3797-805. PubMed ID: 8809167 [TBL] [Abstract][Full Text] [Related]
6. Solid-phase synthesis and evaluation of libraries of substituted 4,5-dihydropyridazinones as vasodilator agents. Gouault N; Martin-Chouly CA; Lugnier C; Cupif JF; Tonnelier A; Feger F; Lagente V; David M J Pharm Pharmacol; 2004 Aug; 56(8):1029-37. PubMed ID: 15285848 [TBL] [Abstract][Full Text] [Related]
7. Some pyridazinone and phthalazinone derivatives and their vasodilator activities. Demirayak S; Karaburun AC; Kayagil I; Erol K; Sirmagul B Arch Pharm Res; 2004 Jan; 27(1):13-8. PubMed ID: 14969331 [TBL] [Abstract][Full Text] [Related]
8. [Studies on synthesis, anticonvulsant activity and the structure--activity relationships of 6-(substituted phenyl)-3 (2H) pyridazinones]. Xu P; Wang SY; Chen Y; Liu WQ; Tao C Yao Xue Xue Bao; 1991; 26(9):656-60. PubMed ID: 1821084 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization and antihypertensive activity of pyridazinone derivatives. Siddiqui AA; Mishra R; Shaharyar M Eur J Med Chem; 2010 Jun; 45(6):2283-90. PubMed ID: 20189270 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and structure-activity relationship studies of 6-phenyl-4,5-dihydro-3(2H)-pyridazinone derivatives as cardiotonic agents. Wang T; Dong Y; Wang LC; Xiang BR; Chen Z; Qu LB Arzneimittelforschung; 2008; 58(11):569-73. PubMed ID: 19137907 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and bioactivity of 6-phenyl-4,5-dihydro-3(2H)-pyridazinone derivatives. Wang T; Dong Y; Wang LC; Chen Z Arzneimittelforschung; 2007; 57(10):641-6. PubMed ID: 18074757 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of new 4,5-3(2H)pyridazinone derivatives and their cardiotonic, hypotensive, and platelet aggregation inhibition activities. Amin EN; Abdel-Alim AA; Abdel-Moty SG; El-Shorbagi AN; Abdel-Rahman MSh Arch Pharm Res; 2010 Jan; 33(1):25-46. PubMed ID: 20191341 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and vasodilator activity of some pyridazin-3(2 Allam HA; Kamel AA; El-Daly M; George RF Future Med Chem; 2020 Jan; 12(1):37-50. PubMed ID: 31710239 [No Abstract] [Full Text] [Related]
14. Studies of cardiotonic agents. 8. Synthesis and biological activities of optically active 6-(4-(benzylamino)-7-quinazolinyl)-4,5-dihydro-5-methyl-3(2H)- pyridazinone (KF15232). Nomoto Y; Takai H; Ohno T; Nagashima K; Yao K; Yamada K; Kubo K; Ichimura M; Mihara A; Kase H J Med Chem; 1996 Jan; 39(1):297-303. PubMed ID: 8568820 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of some 1,3-dihydro-2H-3-benzazepin-2-ones with a piperazine moiety as bradycardic agents. Liang HY; Zhang DQ; Yue Y; Shi Z; Zhao SY Arch Pharm (Weinheim); 2010 Feb; 343(2):114-9. PubMed ID: 20108265 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and vasodilatory activity of new N-acylhydrazone derivatives, designed as LASSBio-294 analogues. Silva AG; Zapata-Sudo G; Kummerle AE; Fraga CA; Barreiro EJ; Sudo RT Bioorg Med Chem; 2005 May; 13(10):3431-7. PubMed ID: 15848755 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and analgesic and antiinflammatory activity of methyl 6-substituted-3(2h)-pyridazinone-2-ylacetate derivatives. Sahina MF; Badiçoglu B; Gökçe M; Küpeli E; Yeşilada E Arch Pharm (Weinheim); 2004 Aug; 337(8):445-52. PubMed ID: 15293264 [TBL] [Abstract][Full Text] [Related]
18. [Unexpected anti-inflammatory activity of rigid structure derivatives of 6-arylpyridazinone antihypertensives. I. Synthesis and activity of 4,4a-dihydro-5H-indeno[1,2c]pyridazin-3-ones]. Cignarella G; Grella G; Loriga M; Curzu MM; Schiatti G Farmaco Sci; 1978 Nov; 33(11):866-74. PubMed ID: 744241 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and vasodilatory activity of some thiazolo-triazole derivative. Demirayak S; Zitouni G; Chevallet P; Erol K; Kiliç FS Farmaco; 1993 May; 48(5):707-12. PubMed ID: 8343214 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, vasorelaxant activity and 2D-QSAR study of some novel pyridazine derivatives. George RF; Saleh DO Eur J Med Chem; 2016 Jan; 108():663-673. PubMed ID: 26735908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]